HIV-1 drug resistance in treatment-naive chronically infected patients in Jamaica
- PMID: 23744572
- PMCID: PMC4648998
- DOI: 10.3851/IMP2648
HIV-1 drug resistance in treatment-naive chronically infected patients in Jamaica
Abstract
Background: HIV-1 drug resistance in treatment-naive patients has a significant impact on the individual patient as well as implications for the wider population. These effects are amplified in the context of resource-limited settings, which are rapidly expanding access to antiretroviral therapy.
Methods: This cross-sectional survey at a single treatment site in Kingston, Jamaica was designed to identify the prevalence of HIV-1 drug-resistant mutations in chronically infected, treatment-naive patients. Mutations were identified using the Stanford HIV database algorithm and the World Health Organization (WHO) HIV Drug Resistance (HIVDR) surveillance mutations.
Results: The inclusion of 103 cases in the study resulted in 79 (76.6%) amplifiable samples. Genotype analysis revealed that 12.6% (95% CI 5.3, 19.9) were identified as having clinically significant mutations, while 10.1% (95% CI 3.5, 16.7) had WHO HIVDR surveillance mutations.
Conclusions: According to the WHO standard, this study population has a moderate level of HIVDR in treatment-naive patients and strongly implies the need to introduce HIVDR surveillance in Jamaica.
References
-
- Jamaica National HIV/STI Programme. United Nations General Assembly Special Session Country Progress Report 2010. UNAIDS; 2010.
-
- Heslop OD, Smikle MF, Deer D, et al. Human immunodeficiency virus type-1 (HIV-1) subtypes in Jamaica. West Indian Med J. 2005;54:279–82. - PubMed
-
- Figueroa JP, Duncan J, Byfield L, et al. A Comprehensive Response to the HIV/AIDS Epidemic in Jamaica. A Review of the Past 20 Years. West Indian Med J. 2008;57:562. - PubMed
-
- National HIV/STI Programme. National Strategic Plan 2007-2012. Ministry of Health; Jamaica: 2007. [Accessed on January 1,2011]. Available at: http://www.nhpjamaica.org.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
